Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 22, 2022
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
Wed, September 21, 2022
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
Rick Wise Maintained (TMCI) at Strong Buy with Increased Target to $27 on, Sep 21st, 2022
Rick Wise of Stifel, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Increased Target from $24 to $27 on, Sep 21st, 2022.
Rick has made no other calls on TMCI in the last 4 months.
There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Rick's Rating of Hold.
This is the rating of the analyst that currently disagrees with Rick
- Drew Ranieri of "Morgan Stanley" Maintained at Buy with Increased Target to $23 on, Wednesday, August 10th, 2022
